BREAKTHROUGH CANCER RESEARCH

“The results suggest that the biofield treatment administered in the laboratory can induce cell death of brain cancer cells from a distance while at the same time promoting the viability of normal brain cells. Such selective efficacy against cancer cells is the sought after “holy grail” for novel experimental anti-cancer agents and makes this work all the more exciting.

– GARRETT L. YOUNT, PH.D.

California Pacific Medical Center Research Institute,

California, USA